Billy Deitch

Overview

Billy Deitch is a Partner at Oak HC/FT since January 2018[2]. Deitch holds a B.A. in History from Yale University[10] and an MBA from Stanford University Graduate School of Business[11]. As an investor, Deitch has held positions across multiple healthcare technology companies, including current investments at Courier Health[3], Candid Health[4], DispatchHealth[5], Brightline[6], and Everside Health[7]. Deitch previously invested in Mendel.ai from 2022 to 2025[8] and Olive from 2018 to 2023[9].

Career history

1. PartnerJan 2018 to presentOak HC/FT
2. Investor2026 to presentCourier Health
3. Investor2025 to presentCandid Health
4. DInvestor2020 to presentDispatchHealth
5. BInvestor2019 to presentBrightline
6. EHInvestor2018 to presentEverside Health
7. MInvestor2022 to 2025Mendel.ai
8. OInvestor2018 to 2023Olive

Education

1. B.A., History2003 - 2007Yale University
2. Master of Business Administration (MBA)2012 - 2014Stanford University Graduate School of Business